TP53 and inflammatory bowel disease: The most frequent mutations in PSC-IBD-CRCs involve TP53 (63–89%), an early event in IBD-associated tumorigenesis, while mutations in APC are rare (5%), although frequent loss of the 5q arm is observed, suggesting alteration of the WNT pathway through copy loss rather than through direct mutations [93,94,95,96].